Minimum Royalty. In no event will the Royalty payable by Verve to Acuitas for any Licensed Product and without regard to any Royalty reductions under subparagraph (a) and/or (b) above, be less than the Royalty payable using a royalty rate of [**] percent ([**]%) (the “Minimum Royalty”).
Appears in 2 contracts
Sources: Non Exclusive License Agreement (Verve Therapeutics, Inc.), Non Exclusive License Agreement (Verve Therapeutics, Inc.)
Minimum Royalty. In no event will the Royalty payable by Verve to Acuitas for any Licensed Product and without regard to any Royalty reductions under subparagraph (a) and/or or (b) above, be above result in a Royalty payable by Scribe to Acuitas for any Licensed Product that is less than the Royalty payable using a royalty rate of [**] percent ([**]%) (the “Minimum Royalty”).
Appears in 2 contracts
Sources: Development and Option Agreement (Scribe Therapeutics, Inc.), Development and Option Agreement (Scribe Therapeutics, Inc.)
Minimum Royalty. In no event will the Royalty payable by Verve GreenLight to Acuitas for any Licensed Product and without regard to any Royalty reductions under subparagraph (a) and/or (b) above, be less than the Royalty payable using a royalty rate of [***] percent ([**]%) (the “Minimum Royalty”).
Appears in 1 contract
Sources: Non Exclusive License Agreement (Environmental Impact Acquisition Corp)
Minimum Royalty. In no event will the Royalty reductions under subsection (a) or (b) above result in a Royalty payable by Verve Metagenomi to Acuitas for any Licensed Product and without regard to any Royalty reductions under subparagraph (a) and/or (b) above, be that is less than the Royalty payable using a royalty rate of [**] percent (*], or for an Orphan Drug Licensed Product [**]%) *] (the “Minimum Royalty”).
Appears in 1 contract
Minimum Royalty. In no event will the Royalty payable by Verve to Acuitas for any Licensed Product and without regard to any Royalty reductions under subparagraph (a) and/or or (b) above, be above result in a Royalty payable by Omega to Acuitas for any Licensed Product that is less than the Royalty payable using a royalty rate of [***] percent ([***]%) (the “Minimum Royalty”).
Appears in 1 contract
Sources: Non Exclusive License Agreement (Omega Therapeutics, Inc.)